Search Results
Jun 02, 2026, 23:24 ET LI-NING anuncia parceria de longo prazo com Stephen Curry e Curry Brand
iniciativas de cultura esportiva e no envolvimento da próxima geração, à medida que a LI-NING e a Curry Brand avançam juntas para moldar o que está por vir para marcas esportivas globais.
More news about: LI-NING
May 29, 2026, 17:48 ET Avalara nomeia Hugo Sarrazin CEO
mais rápido e entregar mais para nossos clientes e parceiros. Hugo traz a liderança operacional e tecnológica necessária para acelerar o que está por vir."Avançando a IA em Tributação e ConformidadeAvalara continua liderando a evolução da tributação e da conformidade por meio da inovação
More news about: Avalara, Inc.
May 27, 2026, 16:58 ET Gartner prevê que gastos mundiais com Inteligência Artificial crescerão 47% em 2026
tecnologia e hyperscalers", afirma Lovelock. "As organizações corporativas ainda não demonstraram de fato seu potencial de investimento. Isso está por vir, e 2026 será o ano inflexão. Atualmente, as organizações mostram um apetite limitado em usar a Inteligência Artificial para impulsionar mudanças disruptivas
More news about: Gartner
May 27, 2026, 07:00 ET Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
result in an increased therapeutic index. Brii Bio licensed exclusive rights to develop and commercialize elebsiran for the Greater China territory from Vir Biotechnology, Inc. in 2020. In May 2024, the CDE of China's NMPA granted elebsiran Breakthrough Therapy Designation.About Brii BioBrii
More news about: Brii Biosciences Limited
May 12, 2026, 04:38 ET TribeVibe Entertainment sweeps WOW Awards 2026 with five wins, cementing its position as a defining force in India's live entertainment landscape
engage over 4 million students on-ground, powering marquee tours and projects that define the live entertainment landscape. Its marquee projects include Vir Das' Sounds of India tour, Prateek Kuhad's 10-city run, Zakir Khan's Papa Yaar comedy tour, Anuv Jain's Dastakhat Tour, Vishal-Shekhar's Super Hit Tour,
More news about: TribeVibe Entertainment
May 06, 2026, 14:56 ET Crown Racing to Enter IMSA Airbnb Endurance Challenge at COTA with McMurry and Clapham
including its work with Radical Arizona and its growing driver roster across Pro 1340 competition. In 2025, Crown Racing entered the Radical World Finals at VIR with a four-driver Pro 1340 roster that included McMurry, Clapham, Jace Bacon, and Seth Bacon. That program highlighted the organization's increasing
More news about: Crown Concepts
Apr 30, 2026, 11:31 ET IEEE celebra a excelência global em engenharia e tecnologia na Cerimônia de Honrarias de 2026
tecnologia impulsionam um progresso significativo em todos os setores e em todo o mundo, inspirando as gerações futuras a construir o que está por vir."Preparando o caminho para a próxima geraçãoA noite culminou com a Medalha de Honra do IEEE, o maior prêmio da organização,
More news about: IEEE
Apr 26, 2026, 07:00 ET Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
result in an increased therapeutic index. Brii Bio licensed exclusive rights to develop and commercialize elebsiran for the Greater China territory from Vir Biotechnology, Inc. in 2020. In May 2024, the CDE of China's NMPA granted elebsiran Breakthrough Therapy Designation.About Brii BioBrii
More news about: Brii Biosciences Limited
Apr 16, 2026, 10:15 ET Milesight Marks 15th Anniversary, Reinforces "Build Deep with V.I.R" Strategy
multimedia:https://www.prnewswire.com/news-releases/milesight-marks-15th-anniversary-reinforces-build-deep-with-vir-strategy-302740216.htmlSOURCE
More news about: Milesight
Apr 16, 2026, 04:15 ET Milesight Marks 15th Anniversary, Reinforces "Build Deep with V.I.R" Strategy
content:https://www.prnewswire.co.uk/news-releases/milesight-marks-15th-anniversary-reinforces-build-deep-with-vir-strategy-302740228.html
More news about: Milesight
Apr 16, 2026, 04:15 ET Milesight feiert sein 15-jähriges Jubiläum und bekräftigt seine Strategie „Build Deep with V.I.R."
content:https://www.prnewswire.com/news-releases/milesight-feiert-sein-15-jahriges-jubilaum-und-bekraftigt-seine-strategie-build-deep-with-vir-302741595.html
More news about: Milesight
Apr 16, 2026, 04:15 ET Milesight celebra su 15º aniversario y refuerza su estrategia "Construir en profundidad con V.I.R."
content:https://www.prnewswire.com/news-releases/milesight-celebra-su-15-aniversario-y-refuerza-su-estrategia-construir-en-profundidad-con-vir-302741338.html
More news about: Milesight
Apr 16, 2026, 04:15 ET Milesight célèbre son 15e anniversaire et renforce sa stratégie « Build Deep with V.I.R. »
content:https://www.prnewswire.com/news-releases/milesight-celebre-son-15e-anniversaire-et-renforce-sa-strategie--build-deep-with-vir--302741336.html
More news about: Milesight
Apr 16, 2026, 02:15 ET Milesight Marks 15th Anniversary, Reinforces "Build Deep with V.I.R" Strategy
content:https://www.prnewswire.co.uk/news-releases/milesight-marks-15th-anniversary-reinforces-build-deep-with-vir-strategy-302740238.html
More news about: Milesight
Mar 31, 2026, 08:00 ET HR Path fortalece sua expertise em UKG na América do Norte com a aquisição estratégica da Covalence
estamos prontos para gerar impacto relevante e entregar ainda mais valor aos nossos clientes. Estou entusiasmado com as oportunidades que estão por vir e com as soluções inovadoras que construiremos juntos."Contact : Fabienne LATOUR -
More news about: HR Path
Mar 27, 2026, 12:52 ET PTC Therapeutics recebe aprovação regulatória de Sephience™ (Sepiapterina) no Brasil
negociações de preços, cobertura e reembolso de terceiros pagadores para os produtos da PTC ou candidatos a produtos que a PTC comercializa ou pode vir a comercializar no futuro; expectativas com relação ao Sephience, incluindo quaisquer submissões regulatórias e possíveis aprovações, comercialização
More news about: PTC Therapeutics
Mar 26, 2026, 09:00 ET Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
Previously, she served as Executive Vice President and Chief Corporate Affairs Officer at Vir Biotechnology, where she led government affairs, corporate communications, and public-private partnerships. Prior to Vir, she served as Chief Scientific Officer at Agenovir Corporation and held senior R&D leadership
More news about: Parker Institute for Cancer Immunotherapy
Mar 19, 2026, 13:05 ET A Cúpula Global de Turismo Médico e Seguros retorna como o evento de negociação de portas fechadas mais influente do setor
medida que o cenário global de saúde continua a evoluir, esta Cúpula continua sendo o único lugar onde os líderes se reúnem para definir o que está por vir.Para aqueles comprometidos em moldar o futuro do turismo médico e dos seguros internacionais, este não é um evento a ser observado. É um evento
More news about: Medical Tourism Association
Mar 18, 2026, 12:53 ET Gartner aponta as principais previsões para Data & Analytics em 2026
mas colaborando como parceiros. Essas previsões oferecem aos líderes um roteiro para se prepararem para as oportunidades e os desafios que estão por vir."Os analistas do Gartner comentarão mais sobre essas previsões para Data & Analytics na
More news about: Gartner
Mar 05, 2026, 09:00 ET Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Companies delivering next-generation oncology treatments across multiple tumor types include Oncolytics Biotech (NASDAQ: ONCY), Vir Biotechnology (NASDAQ: VIR), Iovance Biotherapeutics (NASDAQ: IOVA), C4 Therapeutics (NASDAQ: CCCC), and Immunocore (NASDAQ: IMCR).
More news about: Equity Insider
Feb 26, 2026, 08:15 ET genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
models; argenx (Belgium), a pioneer in Fc-engineering and FcRn biology; Innate Pharma (France), a leader in natural killer cell-based immunotherapies; and Vir Biotechnology (USA), focused on the development of immunotherapies; among other members. The group collaborated with VIB-Ghent University (Belgium),
More news about: genOway
Feb 26, 2026, 03:15 ET genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
models; argenx (Belgium), a pioneer in Fc-engineering and FcRn biology; Innate Pharma (France), a leader in natural killer cell-based immunotherapies; and Vir Biotechnology (USA), focused on the development of immunotherapies; among other members. The group collaborated with VIB-Ghent University (Belgium),
More news about: genOway
Feb 26, 2026, 03:15 ET genOway: Revolution der Vorhersage von Antikörpertherapien beim Menschen mit einem einzigartigen Mausmodell
und FcRn-Biologie, Innate Pharma (Frankreich), ein führendes Unternehmen im Bereich der auf natürlichen Killerzellen basierenden Immuntherapien, und Vir Biotechnology (USA), das sich auf die Entwicklung von Immuntherapien konzentriert. Die Gruppe arbeitete mit der VIB-Ghent University (Belgien), einem
More news about: genOway
Feb 26, 2026, 03:15 ET genOway:Revolucionando la predicción de terapias con anticuerpos en humanos con un modelo de ratón único
(Bélgica), pionera en ingeniería de Fc y biología de FcRn; Innate Pharma (Francia), líder en inmunoterapias basadas en células asesinas naturales; y Vir Biotechnology (Estados Unidos) enfocada en el desarrollo de inmunoterapias; entre otros miembros. El grupo colaboró con VIB-Ghent University (Bélgica),
More news about: genOway
Feb 26, 2026, 03:15 ET genOway : révolutionner la prédiction des thérapies à base d'anticorps chez l'humain grâce à un modèle murin unique
pionnier de l'ingénierie Fc et de la biologie FcRn ; Innate Pharma (France), un leader des immunothérapies basées sur les cellules tueuses naturelles ; et Vir Biotechnology (États-Unis), spécialisé dans le développement d'immunothérapies, entre autres membres. Le groupe a collaboré avec le VIB-Gand (Belgique),
More news about: genOway